Life sciences spotlight — September 2013 - .PDF file.
DLA Piper has published the second issue of its Life Sciences Spotlight publication for 2013.
- A new wave of regulatory enforcement actions in China
- Australia’s innovation patent
- Best practice disclosure for life sciences companies
- The new workplace bullying laws and performance management
- Can reverse payments in patent settlements constitute criminal cartel conduct?
- Unravelling the helix
If you are registered and logged in to the site, click on the link below to read the DLA Piper briefing. If not, please register or sign in with your details below